Get the Stockscreener App
203.03
1.94%
-4.01
Pre-market:
203.03
Natera Inc stock is traded at $203.03, with a volume of 824.87K.
It is down -1.94% in the last 24 hours and down -1.25% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$207.04
Open:
$207.17
24h Volume:
824.87K
Relative Volume:
0.73
Market Cap:
$28.31B
Revenue:
$2.12B
Net Income/Loss:
$-309.19M
P/E Ratio:
-88.89
EPS:
-2.2841
Net Cash Flow:
$93.57M
1W Performance:
-4.15%
1M Performance:
-1.25%
6M Performance:
+21.90%
1Y Performance:
+42.63%
1-Day Range:
$201.85
$208.60
1-Week Range:
$192.59
$216.64
52-Week Range:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
203.03 | 28.87B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-26 | Initiated | Citigroup | Buy |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-27-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-22-25 | Resumed | Wells Fargo | Equal Weight |
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
ARK Investment Management LLC Decreases Stake in Natera, Inc. $NTRA - MarketBeat
Amova Asset Management Americas Inc. Has $101.13 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera at Raymond James Conference: Strategic Growth and Innovation - Investing.com
How Natera’s 2025 Results and SINERGY Trial Data May Shape Natera (NTRA) Investors’ Expectations - simplywall.st
Signatera Oncology Test Drives Natera’s (NTRA) Growth - Insider Monkey
Picton Mahoney Asset Management Sells 17,139 Shares of Natera, Inc. $NTRA - MarketBeat
Insider Sell: Steven Chapman Sells Shares of Natera Inc (NTRA) - GuruFocus
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 3,950 Shares - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Jonathan Sheena of Natera (NTRA) logs stock sales and new 2,103 RSU grant - Stock Titan
Natera (NTRA) president John Fesko awarded 10,051 RSUs in stock grant - Stock Titan
Natera (NTRA) awards 12,272 RSUs to chief legal officer Rabinowitz - Stock Titan
Natera (NTRA) Stock Trades Up, Here Is Why - Finviz
Morgan Stanley Lowers Price Target for Natera (NTRA) to $250 | N - GuruFocus
Natera (NASDAQ:NTRA) Price Target Lowered to $250.00 at Morgan Stanley - MarketBeat
Strive Asset Management LLC Invests $1.61 Million in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Cuts Price Target on Natera to $250 From $265, Keeps Overweight Rating - marketscreener.com
Rafferty Asset Management LLC Has $7.63 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley cuts Natera stock price target on model update - Investing.com Australia
NTRA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Steven L. Chapman sells large NTRA stake (NASDAQ: NTRA) via broker - Stock Titan
Solomon Moshkevich proposes sale — NTRA (NASDAQ: NTRA) - Stock Titan
Canaccord reiterates Natera stock Buy rating after strong quarter By Investing.com - Investing.com South Africa
Canaccord reiterates Natera stock Buy rating after strong quarter - Investing.com
Natera, Inc. (NTRA) Stock Analysis: A 25% Upside Potential With Strong Buy Ratings - DirectorsTalk Interviews
Natera, Inc. $NTRA Shares Acquired by DNB Asset Management AS - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Acquires 8,630 Shares of Natera, Inc. $NTRA - MarketBeat
American Century Companies Inc. Buys 238,679 Shares of Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Purchased by TD Asset Management Inc - MarketBeat
Handelsbanken Fonder AB Has $21.14 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Assessing Natera (NTRA) Valuation After Recent Share Price Pullback And Long Term Return Strength - Yahoo Finance
Artisan Partners Limited Partnership Raises Holdings in Natera, Inc. $NTRA - MarketBeat
NTRA SEC FilingsNatera Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Forecasting The Future: 10 Analyst Projections For Natera - Sahm
Natera, Inc. (NASDAQ:NTRA) Q4 2025 Earnings Call Transcript - Insider Monkey
Erste Asset Management GmbH Purchases 20,000 Shares of Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Q4 Profit Sparks Questions Around Bullish Earnings Turnaround Narrative - simplywall.st
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - The Motley Fool
Citigroup Inc. Sells 73,833 Shares of Natera, Inc. $NTRA - MarketBeat
Decoding Natera Inc (NTRA): A Strategic SWOT Insight - GuruFocus
NTRA Should I Buy - Intellectia AI
Natera (NASDAQ:NTRA) Posts Quarterly Earnings Results, Beats Expectations By $0.81 EPS - MarketBeat
Natera Presents Signatera MRD Data at ASCO GU Showcasing Potential Across GU Cancers - National Today
NTRA: Wells Fargo Maintains Rating, Raises Price Target to $215 - GuruFocus
Key facts: Natera Q4 2025 revenues rise 39.8%; new products launched; Baird raises price target - TradingView
Natera (NASDAQ:NTRA) Given New $215.00 Price Target at Wells Fargo & Company - MarketBeat
Natera (NASDAQ:NTRA) Shares Down 8.7%Here's What Happened - MarketBeat
Natera Inc earnings beat by $0.88, revenue topped estimates - Investing.com South Africa
Why Natera (NTRA) Shares Are Falling Today - Finviz
Natera, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:NTRA) 2026-02-27 - Seeking Alpha
Evercore ISI Group Maintains Outperform Rating for Natera (NTRA), Raises Price Target | NTRA Stock News - GuruFocus
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.25%
2.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):